DEPLOYDatabase

Incident · Regulatory action

FDA clears Quantum Surgical Epione robot for abdominal tumor ablation

Quantum Surgical's Epione robotic platform received FDA clearance for the abdominal ablation indication. Epione assists physicians in performing percutaneous tumor ablations. The device is also CE marked for abdomen, chest, and musculoskeletal indications. Over 1,400 patients have been treated in Europe and the U.S.

Occurred 2025-03-26 · Quantum Surgical · Investigated by FDA

How to read this record

Incident records on DEPLOY are compiled from public sources (regulatory filings, news reports, and operator disclosures) and reflect what has been reported and tracked to date. They are not legal findings, determinations of fault, or safety ratings, and may be updated as new information is verified. See the sources below for the underlying references.
Track FDA clears Quantum Surgical Epione robot for abdominal tumor ablation

Machine-readable surfaces

Sources (1)

  1. https://www.quantumsurgical.com/news/fda-clears-quantum-surgicals-epione-robot-for-all-abdominal-cancers

Status history

  • Active · 2026-07-06 · agent:depth

Common questions

What happened in FDA clears Quantum Surgical Epione robot for abdominal tumor ablation?
Quantum Surgical's Epione robotic platform received FDA clearance for the abdominal ablation indication. Epione assists physicians in performing percutaneous tumor ablations. The device is also CE marked for abdomen, chest, and musculoskeletal indications. Over 1,400 patients have been treated in Europe and the U.S.
When did this incident occur?
The incident is recorded as occurring on March 26, 2025 on the DEPLOY registry. The date reflects the underlying real-world event, not the registry record's creation date.
Who was involved in FDA clears Quantum Surgical Epione robot for abdominal tumor ablation?
The incident is recorded as involving Quantum Surgical on the DEPLOY registry. No specific robot model is linked to this incident in the registry.
Has anyone responded to FDA clears Quantum Surgical Epione robot for abdominal tumor ablation?
No responses to this incident are recorded on the DEPLOY registry. Operators, manufacturers, or affected parties can submit responses to the editorial team; absence is not a guarantee no response was issued.
What is the current status of FDA clears Quantum Surgical Epione robot for abdominal tumor ablation?
This incident is an active record on the DEPLOY registry; no retraction or correction has been issued.
Methodology: Verified · 1 source (no primary) · last reviewed 2026-07-14

Verification posture

Verified

Low confidence

Review state

Stable

Last reviewed 2026-07-14

Sources by quality tier

1
unclassified
Unclassified source

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Methodology surface for FDA clears Quantum Surgical Epione robot for abdominal tumor ablation.

Deploy Watch

Track this incident.

We notify you when the regulator updates the record, the remedy status changes, or a related incident surfaces.

Canonical ID f8736f5b-ee8d-4949-9b17-902614072b1d